BioCentury | Jul 13, 2020
Targets & Mechanisms

Verge puts ALS target through COVID-19 paces, leaning on preclinical partners

...Corp. before its direct molecular target was known, apilimod was acquired by LAM Therapeutics and renamed...
BioCentury | Jun 27, 2020
Deals

Why the WuXi NextCode split makes strategic sense for the multinational genomics company

...plans on June 23 that would integrate its U.S., Ireland and Icelandic operations under a renamed...
BioCentury | Jun 11, 2020
Deals

Cullinan adds first-in-class asset in hot NK cell checkpoint space

...Cullinan said it assumed control of PDI’s operations, structured the unit as a subsidiary and renamed...
BioCentury | Apr 4, 2020
Product Development

COVID-19 roundup: FDA’s expanded access program for convalescent plasma; plus more funding from BARDA, tests from Eurofins, BD-BioGx, and more

...taking place June 8-11 will now occur online instead of in San Diego. The meeting, renamed...
BioCentury | Jan 2, 2020
Company News

Jan. 3 Company Quick Takes: Illumina, PacBio call off deal; plus Innovax, Innate, J&J-Pulmatrix, Intrexon, Janssen-Provention

...The restructured company, which will sell off the majority of its non-healthcare businesses and be renamed...
BioCentury | Dec 5, 2019
Politics & Policy

H.R. 3 to pass House next week, dead on arrival at Senate

...The House will vote next week on H.R. 3, which has been renamed the Elijah E...
BioCentury | Nov 6, 2019
Politics & Policy

FDA takes next step in new drug reorganization, including revamping oncology review

...Division of Non-malignant Hematology (DNH). Antimicrobial products, neuroscience The Office of Antimicrobial Products has been renamed...
BioCentury | Oct 19, 2019
Finance

Woodford’s empire crumbles. U.K biotech stays standing

...Investment Management was removed as fund manager with immediate effect. The WEIF will also be renamed...
BioCentury | Oct 15, 2019
Financial News

Woodford flagship fund implodes as star fund manager axed

...Investment Management was removed as fund manager with immediate effect. The WEIF will also be renamed...
BioCentury | Oct 7, 2019
Company News

Oct. 7 Company Quick Takes: Editas-MaxCyte, Goldfinch-Takeda, Prometheus-Takeda, DBV and Galderma

...pivotal trials begin. Goldfinch plans to submit an IND for the compound, which it has renamed...
Items per page:
1 - 10 of 328
BioCentury | Jul 13, 2020
Targets & Mechanisms

Verge puts ALS target through COVID-19 paces, leaning on preclinical partners

...Corp. before its direct molecular target was known, apilimod was acquired by LAM Therapeutics and renamed...
BioCentury | Jun 27, 2020
Deals

Why the WuXi NextCode split makes strategic sense for the multinational genomics company

...plans on June 23 that would integrate its U.S., Ireland and Icelandic operations under a renamed...
BioCentury | Jun 11, 2020
Deals

Cullinan adds first-in-class asset in hot NK cell checkpoint space

...Cullinan said it assumed control of PDI’s operations, structured the unit as a subsidiary and renamed...
BioCentury | Apr 4, 2020
Product Development

COVID-19 roundup: FDA’s expanded access program for convalescent plasma; plus more funding from BARDA, tests from Eurofins, BD-BioGx, and more

...taking place June 8-11 will now occur online instead of in San Diego. The meeting, renamed...
BioCentury | Jan 2, 2020
Company News

Jan. 3 Company Quick Takes: Illumina, PacBio call off deal; plus Innovax, Innate, J&J-Pulmatrix, Intrexon, Janssen-Provention

...The restructured company, which will sell off the majority of its non-healthcare businesses and be renamed...
BioCentury | Dec 5, 2019
Politics & Policy

H.R. 3 to pass House next week, dead on arrival at Senate

...The House will vote next week on H.R. 3, which has been renamed the Elijah E...
BioCentury | Nov 6, 2019
Politics & Policy

FDA takes next step in new drug reorganization, including revamping oncology review

...Division of Non-malignant Hematology (DNH). Antimicrobial products, neuroscience The Office of Antimicrobial Products has been renamed...
BioCentury | Oct 19, 2019
Finance

Woodford’s empire crumbles. U.K biotech stays standing

...Investment Management was removed as fund manager with immediate effect. The WEIF will also be renamed...
BioCentury | Oct 15, 2019
Financial News

Woodford flagship fund implodes as star fund manager axed

...Investment Management was removed as fund manager with immediate effect. The WEIF will also be renamed...
BioCentury | Oct 7, 2019
Company News

Oct. 7 Company Quick Takes: Editas-MaxCyte, Goldfinch-Takeda, Prometheus-Takeda, DBV and Galderma

...pivotal trials begin. Goldfinch plans to submit an IND for the compound, which it has renamed...
Items per page:
1 - 10 of 328